Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 65
Filter
Add more filters

Publication year range
1.
Public Health ; 226: 128-137, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38056400

ABSTRACT

OBJECTIVE: The purpose was to analyze age-standardized trends in diabetes mortality rates (DMR) from 1998 to 2022, stratified by sex and Mexican state, and the effects attributable to age, period, and cohort by sex. STUDY DESIGN: Joinpoint regression and age-period-cohort effect analysis. METHODS: Based on the tenth revision of the International Classification of Diseases, E11, E12, E13, and E14 codes of the death certificate, a daily record of mortality was extracted from the death certificate attributable to diabetes as the main cause. From 1998 to 2022, sexes and ages (≥20 years) were used to calculate the crude mortality rates and standardized at the national and Mexican state levels. Additionally, the age-period-cohort model was used to examine age, period, and cohort effects. RESULTS: From 1998 to 2005, the age-adjusted DMR increased by 3.6% (95% confidence interval [CI]: 2.7, 4.5) for the total population, as shown by the joinpoint regression analysis at a national level; from 2017 to 2020, it increased by 7.4% (95% CI: 0.6, 14.8). The DMR with the highest increase during the study period came mainly from states in the country's southeastern region, 2.3% to 3.7% per year. The net age and period effects showed that mortality increased with advancing age and with going time, respectively; and the net cohort effect revealed that mortality increased in more recent birth cohorts, mainly in men Rate Ratio (RR) = 2.37 (95% CI: 2.29, 2.46) vs RR = 1.13 (95% CI: 1.09, 1.17). CONCLUSION: The DMR increased among older age groups. The period effect showed that mortality increased over time. Furthermore, the cohort effect showed that mortality increased in more recent birth cohorts, especially among men.


Subject(s)
Diabetes Mellitus , Male , Humans , Aged , Cohort Effect , Mexico/epidemiology , Cohort Studies , Regression Analysis , Mortality
2.
Prev Med ; 86: 147-52, 2016 May.
Article in English | MEDLINE | ID: mdl-26944518

ABSTRACT

OBJECTIVE: To compare the current breast cancer prevention and control Mexican standard with recommendations that health care professionals provide to women for breast self-exams, clinical breast exams and mammography, as well as health care professional knowledge of the risk factors for and main clinical signs of the disease. METHODS: In 2012, using a cross-sectional design, trained interviewers surveyed health care providers in a sample of 798 medical units, of which 756 corresponded to the first and second levels of medical care. One health care professional from each unit was interviewed for the study. The sampling method was systematic and representative of the national and regional levels. Relative frequencies and 95% confidence intervals (CI) were obtained using the weighting factor assigned to each medical unit. RESULTS: Regarding the indicator about recommendations provided to the population regarding early screening for and risk factors and clinical signs of breast cancer, the average number of health care professional responses in accordance with the Mexican standard was 10.7 (95% CI 10.0-11.4) out of a maximum of 28 points, which corresponds to an average rate of 38.2% of responses (95% CI 35.6-40.8). The percentage of correct answers increased in all areas of breast exam knowledge as training hours in the previous year increased. CONCLUSIONS: Health care professionals are unaware of the current standards on breast cancer; therefore, these recommendations are not routinely translated into health care practice, which is a barrier to increasing the coverage of screening programs in health care services.


Subject(s)
Breast Neoplasms/diagnosis , Early Detection of Cancer/statistics & numerical data , Health Knowledge, Attitudes, Practice , Health Personnel/statistics & numerical data , Adult , Aged , Cross-Sectional Studies , Female , Health Personnel/psychology , Humans , Interviews as Topic , Male , Mammography/psychology , Mammography/statistics & numerical data , Middle Aged , Morocco/epidemiology , Primary Health Care/statistics & numerical data , Risk Factors , Secondary Care/statistics & numerical data
3.
Nutr Metab Cardiovasc Dis ; 26(6): 534-40, 2016 06.
Article in English | MEDLINE | ID: mdl-27113291

ABSTRACT

BACKGROUND AND AIMS: The number of colony-forming unit (CFU)-Hill colonies has been proposed as a biomarker of vascular function and cardiovascular risk in adults but information about its role in children is scarce. This study evaluates the associations between obesity, cardiovascular risk factors and breastfeeding history with the numbers of CFU-Hill colonies in a sample of young people. METHODS AND RESULTS: We selected 49 children and teenagers between ages 10 and 17 (65.3% boys) from Mexican Health Care system. Physical activity and Anthropometric measures data were registered. CFU-Hill colonies were cultured from mononuclear cells obtained from venous blood. We detected inverse associations between the formation of CFU-Hill colonies and body mass index (BMI; ß = -1.53; 95% confidence interval [CI], -1.92, -1.13), triglycerides (ß = -0.26; 95%CI = -0.34, -0.18), total cholesterol (ß = -0.13; 95%CI = -0.17, -0.08), Low Density Lipoprotein (LDL) (ß = -0.20; 95%CI = -0.31, -0.09) and glucose (ß = -0.37; 95%CI = -0.55, -0.18) using multivariate models. Breastfeeding duration showed a 1.46-colony increase for each month of breastfeeding (95%CI = 0.73, 2.18). CONCLUSIONS: CFU-Hill colony-forming capacity in children and teenagers was inversely associated with obesity, dyslipidemia and high blood levels of glucose. In contrast a longer breastfeeding duration was directly associated with an increased number of CFU-Hill colonies. However these results must be confirmed with further studies. Our findings support the importance of promoting breastfeeding and monitoring nutritional and metabolic status at an early age to prevent chronic disease development.


Subject(s)
Breast Feeding , Dyslipidemias/pathology , Endothelial Progenitor Cells/pathology , Pediatric Obesity/pathology , Adolescent , Age Factors , Biomarkers/blood , Blood Glucose/metabolism , Cells, Cultured , Child , Child Nutritional Physiological Phenomena , Colony-Forming Units Assay , Cross-Sectional Studies , Dyslipidemias/blood , Dyslipidemias/diagnosis , Dyslipidemias/prevention & control , Endothelial Progenitor Cells/metabolism , Female , Healthy Lifestyle , Humans , Lipids/blood , Male , Mexico , Nutritional Status , Pediatric Obesity/blood , Pediatric Obesity/diagnosis , Pediatric Obesity/prevention & control , Phenotype
4.
Oral Dis ; 22(8): 781-790, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27470907

ABSTRACT

OBJECTIVES: This cross-sectional study examined the distribution and correlates of salivary secretory leukocyte protease inhibitor (SLPI) concentrations within a multinational cohort of men. METHODS: Extracellular SLPI was measured in oral gargle cell supernatants of 378 men from three countries using an ELISA-based assay. Risk factor data were collected by a questionnaire. Factors associated with SLPI were assessed using linear and logistic regression for continuous and categorical SLPI, respectively. RESULTS: Among men aged 18-73 years, the median SLPI concentration was 492.0 ng ml-1 (range: 2.3-1919.9). In multivariable modeling, men in Brazil and younger men (18-30 years) were more likely to have higher levels of SLPI [adjusted odds ratio (aOR) 3.84; 95% confidence interval (CI): 1.94-7.59, and aOR 3.84; 95% CI: 1.98-7.43, respectively]. Men with a self-reported sexually transmitted diseases diagnosis in the past 6 months were more likely to have higher SLPI levels (aOR 2.98; 95% CI: 1.1-7.83) and men reporting bleeding/swollen gums were less likely to have higher SLPI (aOR 0.34; 95% CI: 0.15-0.79). Similar results were observed for linear regression models. CONCLUSIONS: Secretory leukocyte protease inhibitor concentrations varied significantly by country and decreased with increasing age. The interaction between SLPI, modifiable factors, and oral infections that influence cancer risk warrants further investigation.


Subject(s)
Saliva/chemistry , Secretory Leukocyte Peptidase Inhibitor/analysis , Adolescent , Adult , Age Factors , Aged , Cross-Sectional Studies , Gingivitis/metabolism , Humans , Male , Middle Aged , Sexually Transmitted Diseases/metabolism , Young Adult
5.
Epidemiol Infect ; 142(4): 706-13, 2014 Apr.
Article in English | MEDLINE | ID: mdl-23734968

ABSTRACT

SUMMARY Serum samples collected during the National Health and Nutrition survey (ENSANUT 2006) were obtained from subjects aged 1-95 years (January-October 2010) and analysed to assess the seroprevalence of Bordetella pertussis (BP) in Mexico. Subjects' gender, age, geographical region and socioeconomic status were extracted from the survey and compiled into a subset database. A total of 3344 subjects (median age 29 years, range 1-95 years) were included in the analysis. Overall, BP seroprevalence was 47.4%. BP seroprevalence was significantly higher in males (53.4%, P = 0.0007) and highest in children (59.3%) decreasing with advancing age (P = 0.0008). BP seroprevalence was not significantly different between regions (P = 0.1918) and between subjects of socioeconomic status (P = 0.0808). Women, adolescents and young adults were identified as potential sources of infection to infants. Booster vaccination for adolescents and primary contacts (including mothers) for newborns and infants may provide an important public health intervention to reduce the disease burden.


Subject(s)
Whooping Cough/epidemiology , Whooping Cough/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Antibodies, Bacterial/blood , Bordetella pertussis/immunology , Chi-Square Distribution , Child , Child, Preschool , Cross-Sectional Studies , Female , Humans , Infant , Male , Mexico/epidemiology , Middle Aged , Pertussis Vaccine , Seroepidemiologic Studies , Whooping Cough/microbiology , Whooping Cough/prevention & control , Young Adult
6.
Hum Vaccin Immunother ; 15(7-8): 1986-1994, 2019.
Article in English | MEDLINE | ID: mdl-31184976

ABSTRACT

There has been a noticeable shift in discussions about cervical cancer, moving from prevention to elimination. Interventions such as FASTER, human papillomavirus (HPV) vaccination and HPV screening are innovative intervention strategies which can be utilized to begin a path to elimination. To explore the feasibility of the FASTER strategy, an evaluation was carried out in eight primary health-care centers within the Tlalpan Health-Jurisdiction of Mexico City between March 2017 and August 2018. A mixed methods approach was used to evaluate three components: infrastructure, patient acceptability, and health-care professionals' perceptions. This included checklists of requirements for the infrastructure rollout of FASTER and interviews with women and health-care professionals. Nearly all (93%) of the 3,474 women aged 25-45 years accepted HPV vaccination as part of a combined vaccination and screening program. The main reason for acceptance was prevention, while having doubts about the vaccine's benefits was the main reason for refusal. Most of the 24 health-care professionals had a positive opinion toward HPV vaccination and identified the need to increase dissemination, inform the population clearly and concisely and currently extend the age range for vaccination. The evaluation of eight primary health-care centers showed they had the necessary infrastructure for the development of a joint HPV prevention strategy, but many centers required improvements to become more efficient. Together these findings suggest that although HPV vaccine acceptance was high, there is the need to increase education and awareness among potential vaccine recipients and health-care professionals to implement the FASTER strategy.


Subject(s)
Health Knowledge, Attitudes, Practice , Mass Screening , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/administration & dosage , Primary Health Care/statistics & numerical data , Vaccination/methods , Adult , Feasibility Studies , Female , Humans , Mexico , Middle Aged , Patient Acceptance of Health Care , Uterine Cervical Neoplasms/prevention & control , Uterine Cervical Neoplasms/virology
8.
Cancer Res ; 59(15): 3658-62, 1999 Aug 01.
Article in English | MEDLINE | ID: mdl-10446978

ABSTRACT

A case-control study was carried out in Mexico City during 1995-1997 among women with epithelial ovarian cancer (84 cases) and endometrial cancer (85 cases). The control group consisted of 668 healthy women, matched according to age categories. In a multivariate analysis, the reproductive risk factors for ovarian and endometrial cancer are similar. The risk of ovarian cancer was inversely related to the number of full-term pregnancies; the odds ratio (OR) was 0.17 and the 95% confidence interval (CI) was 0.05-0.54 when comparing nulliparous women versus those with more than seven pregnancies. For endometrial cancer, a similar association was observed (OR, 0.11; 95% CI, 0.04-0.34). The use of oral contraceptive hormones was inversely associated with both ovarian (OR, 0.36; 95% CI, 0.15-0.83) and endometrial cancer risk (OR, 0.36; 95% CI, 0.14-0.90). In women with a history of more than 8.7 years without ovulation, the risk of ovarian cancer decreased four times (OR, 0.23; 95% CI, 0.10-0.50), and that of endometrial cancer decreased more than five times (OR, 0.17; 95% CI, 0.08-0.35). These two neoplasms are clearly typified as hormone dependent, and it is possible to establish that "ovulation" and "exfoliative" mechanisms jointly determine the level of risk for both ovarian and endometrial cancer.


Subject(s)
Endometrial Neoplasms/epidemiology , Estrogens , Neoplasms, Hormone-Dependent/epidemiology , Ovarian Neoplasms/epidemiology , Parity , Progesterone , Reproductive History , Breast Feeding/statistics & numerical data , Case-Control Studies , Contraceptives, Oral, Hormonal , Female , Hormone Replacement Therapy , Humans , Intrauterine Devices , Menarche , Menopause , Mexico/epidemiology , Middle Aged , Models, Biological , Ovulation , Risk Factors
9.
Drug Alcohol Depend ; 77(1): 93-6, 2005 Jan 07.
Article in English | MEDLINE | ID: mdl-15607846

ABSTRACT

UNLABELLED: In this study, we explored if patterns in the transition from alcohol/tobacco in the Mexican State of Morelos, Mexico are similar to those observed in other countries. METHODS: The data were from a representative sample of youth age 11-21 years (n = 13,105), who participated in a paper-and-pencil survey in middle schools, high schools, and colleges in the State of Morelos, Mexico. Drug use was assessed via the standardized instrument mostly used in Mexican student surveys. Cox's models for discrete time-survival analyses, stratified by school and age group were used to estimate the risk of drug use in relation to age of alcohol and tobacco use initiation by gender, while accommodating the complex survey design. RESULTS: About 5% of the students were estimated to have used drugs in their life. Male early users of alcohol or tobacco were more likely to use other drugs, compared to students who did not have an early alcohol or tobacco onset. COMMENT: Further studies on social mechanisms might help to account for observed similarities in patterns of drug involvement in different countries, even in the context of important differences in rates of drug use.


Subject(s)
Alcohol Drinking/epidemiology , Smoking/epidemiology , Students , Substance-Related Disorders/epidemiology , Adolescent , Adult , Age Factors , Child , Female , Humans , Male , Mexico/epidemiology , Proportional Hazards Models
10.
Acta Diabetol ; 42(1): 36-45, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15868112

ABSTRACT

The main aim of this study was to evaluate correlates of the knowledge Mexican young people have about type 2 diabetes mellitus (DM) risk and prevention. We developed a cross-sectional study in public schools in Morelos, in central Mexico during 1998-1999 in 13,293 students (11-24 years). We determined body mass index (BMI) with anthropometric measurements (height and weight). Using questionnaire data, we constructed a DM knowledge-based scale. Statistical analysis was done using an ordinal, logistic regression model. Only 1.6% of the students (95%CI = 1.4-1.8) had high DM knowledge levels; 85.6% (95%CI = 84.9-86.1) had low levels. The factors with the strongest associations with high levels of knowledge about type 2 DM among the Mexican students in this study were: being in high school or at university (vs. junior high), urban residence, higher socio-economic level, and BMI indicating overweight or obesity. Other socio-demographic factors correlated with high levels of knowledge about the disease, but with slightly weaker associations, included female gender, higher age, higher academic achievement (grades) and higher education level of the student's mother. While young men who were overweight or obese were 2.6 and 3.4 times more likely to have high levels of knowledge about DM (95%CI = 1.9-3.6 and 2.1-5.5, respectively), young women who were overweight or obese were only 1.4 and 1.1 times more likely to have high knowledge about DM (95%CI = 1.0-1.9 and 0.6-1.8, respectively). Mexican young people have limited knowledge about DM, although this chronic disease is increasingly common in Mexico as in many other countries.


Subject(s)
Diabetes Mellitus, Type 2/prevention & control , Health Knowledge, Attitudes, Practice , Adolescent , Adult , Body Mass Index , Child , Cross-Sectional Studies , Female , Humans , Male , Mexico , Rural Population , Sex Factors , Socioeconomic Factors , Students , Urban Population
11.
Clin Microbiol Infect ; 21(5): 502-9, 2015 May.
Article in English | MEDLINE | ID: mdl-25698660

ABSTRACT

Human papillomavirus (HPV) infections are associated with the development of anogenital lesions in men. There are no reports describing the distribution of non-α HPV types in the anal canal of a sexually diverse group of men. The HPV Infection in Men (HIM) Study is a multicentre study on the natural history of HPV infection in Brazil, Mexico, and the USA. At baseline, 12% of anal canal PCR HPV-positive specimens were not typed by the Roche Linear Array, and were considered to be unclassified. Our goals were to characterize HPVs among these unclassified specimens at baseline, and to assess associations with participant socio-demographic and behavioural characteristics. Unclassified HPVs were typed by sequencing of amplified PGMY09/11 products or cloning of PGMY/GP + nested amplicons followed by sequencing. Further analysis was conducted with FAP primers. Of men with unclassified HPV in the anal canal, most (89.1%) were men who have sex with women. Readable sequences were produced for 62.8% of unclassified specimens, of which 75.2% were characterized HPV types. Eighteen, 26 and three different α-HPV, ß-HPV and γ-HPV types were detected, respectively. α-HPVs were more commonly detected among young men (18-30 years) than among older men (45-70 years), whereas ß-HPVs were more frequent among mid-adult men (31-44 years). ß-HPVs were more common among heterosexual men (85.0%) than among non-heterosexual men. All ß-HPVs detected among non-heterosexual men were ß2-HPV types. The high prevalence of ß-HPV in the anal canal of men who do not report receptive anal sex is suggestive of other forms of transmission that do not involve penile-anal intercourse.


Subject(s)
Anal Canal/virology , Genetic Variation , Genotype , Papillomaviridae/classification , Papillomaviridae/isolation & purification , Papillomavirus Infections/epidemiology , Papillomavirus Infections/virology , Adolescent , Adult , Aged , Behavior , Brazil/epidemiology , Cross-Sectional Studies , Demography , Female , Genotyping Techniques , Humans , Male , Mexico/epidemiology , Middle Aged , Molecular Epidemiology , Sequence Analysis, DNA , United States/epidemiology , Young Adult
12.
Int J Epidemiol ; 27(3): 370-6, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9698122

ABSTRACT

BACKGROUND: This study presents the evaluation of the Mexico City Cervical Cancer Screening Programme (CCSP). Uterine cervical cancer (CC) is still a major public health problem in Mexico. Various actions aimed at reducing mortality from CC have been unsuccessful with an estimated 62000 deaths reported between 1980 and 1995. METHODS: The authors performed a study of cases and controls chosen on a population basis that included a sample of 233 cases of cancer in situ, and 397 cases of invasive cervical cancer obtained from eight hospitals, and a sample of 1005 controls representative of the general population. The results are presented stratified by case type, classified according to whether the cancer is invasive or not. RESULTS: The results show low impact of the cervical cancer screening programme in Mexico. Women who had a history of use of the Papanicolaou smear (PAP), who did not seek testing due to gynaecological symptoms and who had received their PAP results, had a 2.63 times lower risk of developing invasive cervical cancer (OR = 0.38; 95% CI: 0.28-0.52). CONCLUSIONS: The principal findings of this study in relation to the low impact of the screening programme in Mexico, are the low level of existing coverage and late use of health services by women at risk.


Subject(s)
Developing Countries , Mass Screening/statistics & numerical data , Uterine Cervical Neoplasms/mortality , Adolescent , Adult , Aged , Carcinoma in Situ/diagnosis , Carcinoma in Situ/mortality , Carcinoma in Situ/pathology , Case-Control Studies , Cause of Death , Cross-Sectional Studies , Female , Humans , Incidence , Mexico/epidemiology , Middle Aged , Neoplasm Invasiveness , Neoplasm Staging , Papanicolaou Test , Risk Factors , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/pathology , Vaginal Smears/statistics & numerical data
13.
Arch Med Res ; 30(3): 240-50, 1999.
Article in English | MEDLINE | ID: mdl-10427875

ABSTRACT

BACKGROUND: Mexico established a national cervical cancer-screening program in 1974. Despite the implementation of the program, there was a steady mortality trend of 16 per 100,000 women over 15 years. METHODS: A diagnostic procedure of the pitfalls was applied to the following steps of the screening procedure: Pap sampling quality; cytological diagnosis validity; compliance of women; and determinants of non-participation. RESULTS: The low effectiveness of screening on cervical cancer is principally due to factors associated with quality and coverage. Pap quality is deficient; 64% of a random sample of specimens lacked endocervical cells. Reading centers presented false negative indices of between 10 and 54%. Women seek screening in a late stage of disease (55% with cervical cancer seek care because they have symptoms). In addition, coverage is low; in women between 15 and 49 years of age in Mexico City, 64.2% have a history of Pap, compared with 30% in rural areas. Knowledge of what the Pap is used for strongly determines the use of screening. In rural areas, only 40% of women are informed about the purpose of the Pap test. CONCLUSIONS: A proposal to reorganize Mexico's screening program includes the following five main strategies: (a) increased coverage; (b) improved quality control of how cervical smears are taken; (c) better interpretation of Pap tests; (d) guaranteed treatment for those whose tests show abnormalities, and (e) improved follow-up.


Subject(s)
Mass Screening/methods , Uterine Cervical Neoplasms/diagnosis , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Mexico , Middle Aged
14.
Arch Med Res ; 32(3): 243-7, 2001.
Article in English | MEDLINE | ID: mdl-11395192

ABSTRACT

BACKGROUND: A scenario that must be considered when testing prophylactic human papillomavirus (HPV) vaccines in teenagers is the parents' acceptability of their daughters' participation in the study. METHODS: A survey was carried out in a random sample of 880 women between the ages of 15 and 49 years in the metropolitan area of Cuernavaca, Mexico. These women were interviewed to obtain information concerning their knowledge of risk factors for cervical cancer and their perception of the usefulness of vaccines. Afterward, they were provided with information on the main risk factors for cervical cancer and the future availability of a human papillomavirus (HPV) vaccine to prevent cervical cancer. Finally, we explored, with parents, the possible acceptability of an HPV vaccine for their teenaged daughters. The degree of acceptability and its association with a series of sociodemographic and reproductive factors were assessed. RESULTS: The respondents had little knowledge regarding the etiology of cervical cancer. Only 1.9% said that the principal risk factor was infection with HPV; however, 84.2% were aware of the usefulness of vaccines and 83.6% of the women indicated that they would allow their daughters to participate in a trial to evaluate the effectiveness of an HPV vaccine that helps prevent cervical cancer. The main factor associated with the acceptance of a possible vaccine against HPV was the knowledge of the usefulness of vaccines [odds ratio (OR) = 6.5, 95% confidence interval (CI) 5.2-8.2]. Likewise, a history of two or more sexual partners (OR = 2.2, 95% CI 1.3-3.6) increased acceptability. Acceptance was not associated with the number of live births (never vs. ever OR = 0.9, 95% CI 0.3-2.1). There were 525 women with children over the age of 10 years (59.6%); prevalence of acceptability among these women was 80.1%, not statistically different from the remainder of the sample (p >0.05). CONCLUSIONS: Acceptance of a potential HPV vaccine was high in this sample of Mexican women. Initiation of HPV vaccine clinical trials and immunization campaigns that target school children and/or teenagers who are not sexually active should include educational programs aimed at mothers of these individuals. Knowledge of the benefits of a preventive vaccine as well as the etiology and risk factors of cervical cancer should be emphasized.


Subject(s)
Attitude to Health , Mothers , Papillomaviridae/immunology , Papillomavirus Vaccines , Tumor Virus Infections/prevention & control , Uterine Cervical Neoplasms/prevention & control , Viral Vaccines/administration & dosage , Adolescent , Adult , Female , Humans , Interviews as Topic , Mexico , Middle Aged , Risk Factors , Tumor Virus Infections/virology , Uterine Cervical Neoplasms/virology
15.
Arch Med Res ; 28(2): 265-71, 1997.
Article in English | MEDLINE | ID: mdl-9204620

ABSTRACT

Cervical cancer (CC) is one of the principal public health problems in Mexico. The national mortality rate due to CC was estimated at 21.8 per 100,000 among women over 15 years old during 1994. Despite this high incidence little is known in Mexico about the risk factors for CC. The objectives of the study were to evaluate the association between CC and HPV types 16 and 18 in women living in Mexico City. From August, 1990 to December, 1992, a case-control study was carried out in the metropolitan area of Mexico City. HPV 16-18 types were determined in a sample of 148 CC cases and 204 controls randomly selected from a sample frame representative of the metropolitan area of Mexico City. Sixty cases corresponded to in situ CC and 88 cases to the invasive phase. Determination of HPV 16 and 18 types was done by polymerase chain reaction using primers specific to E6/E7. Results showed that 48.3% of in situ CC cases and 48.8% of invasive CC cases were positive for HPV 16 while only 13.2% were positive among the 204 controls. Association between HPV 16 infection in the in situ cancer cases had an estimated odds ratio (OR) of 5.17 (95% CI 2.60-10.51). In the invasive cervical cancer cases, association between HPV 16 infection and invasive CC in this sample had an OR of 3.84 (95% CI 2.04-7.22). For the total sample, the estimated OR was 5.48 (95% CI 3.07-9.62). In the total sample, those women with a strong positive reaction to PCR were associated with a large increase in the risk, OR of 38.0 (95% CI 8.66-167.1). The prevalence the HPV 18 was 6.7%, only observed in the invasive cervical cancer cases. At present there is general consensus that HPV is the principal causal agent in C C etiology. This study intends to contribute to the knowledge concerning the etiology of cervical cancer. However, it is necessary to consider that the single most effective tool in the reduction of mortality due to cervical cancer has been the Pap test. Secondary prevention has proven to be highly effective in other populations, and this should be viewed as a priority activity for all at-risk populations. Although a vaccine for HPV may be available in the near future its efficacy in primary prevention has yet to be demonstrated.


Subject(s)
Carcinoma/epidemiology , Papillomaviridae/isolation & purification , Papillomavirus Infections/epidemiology , Tumor Virus Infections/epidemiology , Uterine Cervical Neoplasms/epidemiology , Adolescent , Adult , Aged , Carcinoma/etiology , Carcinoma/virology , Case-Control Studies , Comorbidity , DNA Probes, HPV , Female , Humans , Mexico/epidemiology , Middle Aged , Papillomaviridae/classification , Papillomavirus Infections/virology , Polymerase Chain Reaction , Reproductive History , Risk Factors , Sexual Behavior , Tumor Virus Infections/virology , Uterine Cervical Neoplasms/etiology , Uterine Cervical Neoplasms/virology , Uterine Cervical Dysplasia/epidemiology , Uterine Cervical Dysplasia/virology
16.
Arch Med Res ; 28(4): 565-70, 1997.
Article in English | MEDLINE | ID: mdl-9428585

ABSTRACT

Lung cancer (LC) is one of the most important public health problems in the world; 1,035,000 annual deaths are estimated each year and more than 80% of these are attributed to tobacco. The trend of lung cancer mortality in Mexico City from 1979 - 1993 was determined, as was the rate ratio of lung cancer mortality in 31 states in Mexico, taking Mexico City as a reference by means of a Poisson model. A strong linear regression model was used to evaluate the rate, where the dependent variable was LC mortality rate and the independent variable the year observed. In 15 years, 73,807 deaths from LC were reported, with an increase in mortality from 5.01 - 7.25 per 100,000 inhabitants. Mortality increases significantly after 60 years of age (B not equal to 0), p<.05) in men and in women. Mortality from LC was 70% in men, and more than 60% of deaths were reported after 65 years of age. Mortality risk is higher in the northern states of the country (e.g., Sonora, RR=2.40) than in the southern region (e.g., Oaxaca RR=0.40). In Mexico, almost 10,000 deaths by LC are estimated for the year 2010. Therefore, changes in lifestyle should be encouraged in order to decrease the smoking habit. The governmental tax on cigarettes should be increased, smoking restricted in squares and public spaces, and the risks should be announced on cigarette packages, among other measures. With respect to other emergent risk factors, the sources of industrial pollution and toxic emissions should be regulated.


Subject(s)
Lung Neoplasms/mortality , Adult , Aged , Female , Humans , Male , Mexico/epidemiology , Middle Aged , Mortality/trends
17.
Int J Gynaecol Obstet ; 56(2): 155-62, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9061390

ABSTRACT

OBJECTIVE: A survey that compared two alternatives (conservative and radical surgery) is presented on ovarian cancer treatment evaluating its effect on progression-free survival and fertility, in a 10-year time period, in Mexican women. METHODS: 72 women between 11 and 58 years old with unilateral ovarian cancer in different stages were studied. Several methods were analyzed: (1) progression-free survival, using Mantel and Haenzsel test to compare in terms of life curves and the Kaplan-Meier method. The exposure variable was surgery type, using the Mantel-Cox test to evaluate the difference in life curves by clinical stages and by surgery type; (2) fertility was evaluated in women who received conservative surgery, considering the cumulative pregnancy rate in women successfully pregnant after surgical and/or adjuvant treatment. RESULTS: There were no difference in survival curves when evaluating progression-free survival, in either group (Z = 1.09 and Pr > (z) = 0.27). During the study period, we found that 87.5% of patients were alive with no evidence of disease. There were no differences in survival curves when evaluating progression-free survival according to surgery type and clinical stage (chi 2 = 0.66, P = 0.88). Restart of menstruation in patients with conservative surgery occurred before 6 months in 89% of the sample, 22 women with possible parity had a 59.1% cumulative pregnancy rate. CONCLUSION: The outcomes from this survey carried out in Mexico show that conservative treatment of ovarian cancer in early clinical stages is an efficient alternative to preserve reproductive function in young women, and does not show differences in progression-free survival compared to radical surgery.


Subject(s)
Adenocarcinoma/surgery , Fertility , Neoplasms, Germ Cell and Embryonal/surgery , Ovarian Neoplasms/surgery , Adolescent , Adult , Analysis of Variance , Child , Disease-Free Survival , Female , Humans , Hysterectomy , Life Tables , Middle Aged , Ovariectomy , Pregnancy , Prognosis
18.
Int J Gynaecol Obstet ; 53(2): 159-66, 1996 May.
Article in English | MEDLINE | ID: mdl-8735297

ABSTRACT

OBJECTIVES: The average age of menopause among women in Mexico City was calculated, considering their reproductive and socio-demographic characteristics. The information was obtained from a population-based control group from a case-controlled study of gynecologic cancer. METHODS: Interviews were carried out with 1005 women resident in Mexico City chosen at random from a sample using the housing sample framework of the Mexico General Directorate of Epidemiology, 472 of whom had undergone a natural menopause. RESULTS: The most important results include an average age for menopause in this population of 46.5 +/- 5 years (95% C.I. 46-48) with a median of 47. Groups of women with an average early menopause were those with no formal education (1.6 years), low socio-economic level (1.3 years, P < 0.05), nulliparas (2.6 years, P < 0.05), those who had never breastfed (2.2 years, P < 0.05) and those who had not used contraceptive hormones (1.7 years, P < 0.05). CONCLUSION: This phenomenon must be documented in Mexico because of its strong links with the morbidity and mortality of the growing number of women who are reaching advanced ages and whose survival is calculated at 30 years after menopause.


Subject(s)
Menopause/physiology , Age Factors , Breast Feeding , Contraceptives, Oral, Hormonal/administration & dosage , Female , Humans , Menopause/ethnology , Mexico , Middle Aged , Parity , Socioeconomic Factors
19.
Int J Gynaecol Obstet ; 75(1): 33-42, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11597617

ABSTRACT

OBJECTIVE: To identify prognostic survival factors among Mexican women with cervical cancer. METHODS: A total of 378 women with cervical cancer admitted from 1984 to 1996 to our referral hospital were evaluated, using survival analysis (Kaplan-Meier and Cox proportional hazards method). We designed a symptom index which included asymptomatic conditions, severity of symptoms and comorbidity. RESULTS: Overall 5-year survival was 66.6%. The shortest survival time was for FIGO stage IV (21.5%, P<0.001) and adenosquamous histologic type (53.1%, P=0.15). The main prognostic factors were primary symptoms (RR, 2.6; 95% CI, 1.02-6.66); systemic symptoms (RR, 3.3; 95% CI, 1.23-9.01); FIGO stage IV (RR, 5.5; 95% CI, 2.36-12.96); and oncogenic symptoms (prognostic comorbidity present) (RR, 2.3; 95% CI, 1.08-4.89). CONCLUSIONS: Our findings show that clinical stage and several types of symptoms influence CC survival. This present strategy to assess morphological and clinical characteristics may be a more accurate indicator of survival rate and potentially an efficient indicator of new therapeutic alternatives.


Subject(s)
Adenocarcinoma/mortality , Carcinoma, Adenosquamous/mortality , Neoplasms, Squamous Cell/mortality , Uterine Cervical Neoplasms/mortality , Adenocarcinoma/pathology , Carcinoma, Adenosquamous/pathology , Coitus , Female , Humans , Menarche , Mexico , Middle Aged , Neoplasm Staging , Neoplasms, Squamous Cell/pathology , Parity , Prognosis , Proportional Hazards Models , Risk , Severity of Illness Index , Survival Analysis , Survival Rate , Uterine Cervical Neoplasms/pathology
20.
Diagn Cytopathol ; 17(1): 20-4, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9218898

ABSTRACT

Due to the high rate of false negative results in diagnosis of cervical cytopathology, in many countries its practice has been transformed through the application of several interventions aimed at medical regulation to improve diagnostic accuracy. Diagnostic reproducibility of gynecological cytopathology was evaluated in a series of 20 cytology specimens [Papanicolaou (Pap)] and 20 cervical biopsy. (CB) studies in different clinical stages, during 1994. The observation unit consisted of 30 pathologists who observed 2 groups of 20 Pap and 20 CB specimens. The standard was a cytopathologist certified by the Pathological Anatomy Council of Mexico. Intraclass reproducibility in gynecological cytopathology is low in Mexico. In a group analysis, concordance increased as clinical status of the cervical lesion increased. For moderate dysplasia, concordance in Pap was kappa = 0.04, compared to 0.23 in CB. Concordance of diagnosis of invasive cancer was 0.29 for Pap and 0.64 for CB. Using weighted kappa at the individual level for all possible diagnoses, concordance varied from 0.29 to 0.59 for Pap, and 0.42 to 0.65 for CB. The problem of reproducibility in cervical cytopathology in Mexico emphasizes the need for continuing education, uniform diagnostic criteria, and the advantages of a single operational classification-possibly the Bethesda System-since current classification systems are obsolete.


Subject(s)
Cytodiagnosis/standards , Uterine Cervical Neoplasms/pathology , Accreditation , Biopsy , Female , Humans , Mexico , Observer Variation , Papanicolaou Test , Reproducibility of Results , Vaginal Smears
SELECTION OF CITATIONS
SEARCH DETAIL